{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:57:11Z","timestamp":1715993831868},"reference-count":45,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T00:00:00Z","timestamp":1215388800000},"content-version":"vor","delay-in-days":2709,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2001,2,5]]},"abstract":"<jats:sec><jats:title>Aim:<\/jats:title><jats:p>To evaluate the intestinal ulcerogenic property of nitric oxide\u2010releasing indomethacin (NCX\u2010530) in the rat, in comparison with indomethacin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Animals were given indomethacin or NCX\u2010530 subcutaneously and killed 24\u2003h later for macroscopic examination of the small intestine.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>A single administration of indomethacin (10\u2003mg\/kg) provoked damage, mainly in the jejunum and ileum, accompanied by an increase in myeloperoxidase and inducible nitric oxide synthase activities as well as bacterial translocation. NCX\u2010530 at an equimolar dose (14.2\u2003mg\/kg) caused no gross damage in the small intestine, nor any significant change in inducible nitric oxide synthase and myeloperoxidase activities or bacterial translocation. NOR\u20103, the nitric oxide donor (6.0\u2003mg\/kg), when administered subcutaneously together with indomethacin, significantly prevented the occurrence of intestinal lesions and other mucosal changes. Indomethacin reduced mucus and fluid secretions in the small intestine, while both NCX\u2010530 and NOR\u20103 enhanced these secretions. NCX\u2010530 reduced the mucosal prostaglandin E2 contents and exhibited an anti\u2010inflammatory action against carrageenan\u2010induced paw oedema, with equal effectiveness to indomethacin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>NCX\u2010530 does not cause intestinal damage, despite inhibiting cyclooxygenase activity. The reduced intestinal toxicity of NCX\u2010530 may be attributable to inhibition of enterobacterial translocation, partly by increasing the mucus and fluid secretions mediated by nitric oxide released from this compound.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2001.00916.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:43:42Z","timestamp":1047354222000},"page":"257-267","source":"Crossref","is-referenced-by-count":26,"title":["Lack of small intestinal ulcerogenecity of nitric oxide\u2010releasing indomethacin, NCX\u2010530, in rats"],"prefix":"10.1111","volume":"15","author":[{"given":"H.","family":"Mizoguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,7,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(81)90196-7"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1995.tb15066.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1159\/000138047"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00920471"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.1999.0550"},{"key":"e_1_2_6_7_2","first-page":"259","article-title":"Effect of NS\u2010398, a new nonsteroidal anti\u2010inflammatory agent, on gastric ulceration and acid secretion in rats","volume":"81","author":"Arai I","year":"1993","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9041264"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90074-4"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(94)90136-8"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1997.273.6.G1246"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.115286000.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90341-0"},{"key":"e_1_2_6_14_2","first-page":"115","article-title":"Effect of nitric oxide\u2010releasing aspirin derivative on gastric functional and ulcerogenic responses in rats: Comparison with plain aspirin","volume":"286","author":"Takeuchi K","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018846912032"},{"key":"e_1_2_6_16_2","first-page":"G1440","article-title":"Safety of NO\u2010releasing indomethacin in the stomach: Comparison with indomethacin","volume":"116","author":"Takeuchi K","year":"1999","journal-title":"Gastroenterology"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(94)90703-X"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12506462"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(92)90643-Y"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1993.tb07103.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.21.6.533"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1021\/ac60111a017"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-6980(76)90189-1"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb15475.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1993.tb13940.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1995.tb15066.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(97)01599-9"},{"key":"e_1_2_6_28_2","first-page":"405","article-title":"Dual action of nitric oxide in pathogenesis of indomethacin\u2010induced small intestinal ulceration in rats","volume":"50","author":"Tanaka A","year":"1999","journal-title":"J Physiol Pharmacol"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70225-7"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1999.277.4.H1317"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1999.277.4.G875"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb15301.x"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1990.259.3.C462"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90259-N"},{"key":"e_1_2_6_35_2","first-page":"517P","article-title":"Inhibition of fMLP\u2010induced aggregation of rabbit neutrophils by nitric oxide","volume":"95","author":"McCall T","year":"1998","journal-title":"Br J Pharmacol"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00066.x"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-9896(199607)179:3<340::aid-path558>3.0.co;2-v"},{"key":"e_1_2_6_38_2","first-page":"110","article-title":"Study on the possible neurotransmitter of the non\u2010adrenergic non\u2010cholinergic innervation of the rat gastric fundus","volume":"280","author":"Lefebvre J","year":"1986","journal-title":"Arch Int Pharmacodyn"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701968"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1999.277.4.G847"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00442.x"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(92)90824-N"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1159\/000007804"},{"key":"e_1_2_6_44_2","first-page":"G933","article-title":"Role of nitric oxide in restitution of injured guinea pig gastric mucosa in vitro","volume":"268","author":"Yanaka K","year":"1995","journal-title":"Am J Physiol"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.22.13313"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70370-1"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.00916.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.00916.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2001.00916.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T01:34:22Z","timestamp":1697506462000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2001.00916.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2,5]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,2,5]]}},"alternative-id":["10.1046\/j.1365-2036.2001.00916.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2001.00916.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2,5]]}}}